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The symptoms of schizophrenia are highly variable and include a variety of cognitive deficits, 
including attentional deficit. These cognitive deficits may involve dopamine (DA) underactivity 
in the prefrontal cortex (PFC) (Weinberger, Egan, Bertolino, Callicott, Mattay, Lipska, et al., 
2001). The purpose of this thesis was to test the hypothesis that reduced DA in the PFC alters 
attention by examining the effects of reduced DA in the medial PFC (mPFC) of rats on a 
sustained attention task. Rats in the DA-lesioned group were administered 6-hydroxydopamine 
(6-OHDA) in the mPFC. Following 6-OHDA administration, rats in the DA-lesioned and sham-
lesioned group were trained to nose poke into a lit aperture for food reward in the 5-choice serial 
reaction time task (5-CSRTT), a rodent analogue of the Continuous Performance Task used to 
assess sustained attention in schizophrenics (Robbins, 2002). The 6-OHDA administration 
resulted in depletions of both DA (33% of controls) and norepinephrine (NE) (50% of controls). 
Rats’ performance was assessed by comparing the frequency of correct, incorrect, omitted, and 
premature responses in testing conditions where the duration of stimulus in the 5-CSRTT was 
randomly varied from 2.5 to 0.25 seconds. No significant differences between lesioned and 
control rats were observed in any behavioral testing parameters. However, there was a trend 
toward increased numbers of omissions and reduced correct responses seen in lesioned rats 
especially at the shortest stimulus durations. The trend supports the hypothesis that reduced DA 
in the PFC contributes to attentional dysfunction in schizophrenia. Future studies should examine 
the behavioral effects of 6-OHDA lesions using larger sample sizes. Also, future studies should 
examine rats’ 5-CSRTT performance at stimulus durations less than 0.25 seconds to further 
explore the trend toward poorer performance seen in 6-OHDA lesioned rats.
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Five-Choice Serial Reaction Time Task Performance Following Catecholamine Depletion of 
Rat Medial Prefrontal Cortex:  
Implications for Attention Deficit in Schizophrenia 
Schizophrenia is a disorder characterized by disorganized thoughts, hallucinations and 
delusions, emotional disturbances, and cognitive deficits (Lewis, Hashimoto, & Volk, 2005). It is 
believed to be a neurodevelopmental disorder (Rapoport, Addington, Frangou, & Psych, 2005), 
with the onset of symptoms generally occurring during late adolescence through early adulthood 
(Raedler, Knable, & Weinberger, 1998). Post-mortem analyses of the brains of schizophrenics 
have revealed structural abnormalities such as decreased grey matter volume in the prefrontal 
cortex (PFC) (Hashimoto, Volk, Eggan, Mirnics, Pierri, Sun, et al., 2003; Shenton, Dickey, 
Frumin, & McCarley, 2001). The PFC is not fully developed until early adulthood (Krasnova, 
Betts, Dada, Jefferson, Ladenheim, Becker, et al., 2007), which is also when schizophrenia is 
typically diagnosed. This has led to the hypothesis that abnormal maturation and function of the 
PFC may underlie emergence of the symptoms of schizophrenia (Finlay, 2001).  
Schizophrenia is diagnosed in approximately 1% of the world’s population (Lewis, Cruz, 
Eggan, & Erickson, 2004). Sensory disturbances and psychotic states are common features of the 
illness. Due to the action of antipsychotic drugs, the most extensively studied neurotransmitter 
system in relation to schizophrenia is the monoamine neurotransmitter dopamine (DA) (Guillin, 
Abi-Dargham, & Laruelle, 2007). Antipsychotic drugs ameliorate psychotic symptoms by 
blocking the action of DA at post-synaptic D2 receptors (Meisenzahl, Scheuerecker, Schmitt, & 
Moller, 2007), which suggests that psychotic symptoms occur because of overstimulation of D2 
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receptors. Likewise, drugs that increase DA release, such as amphetamine, can induce psychosis 
and exacerbate the psychotic symptoms of schizophrenia (Abi-Dargham & Moore, 2003).  
The relationship between excessive activity of DA and psychosis has given credence to 
the hypothesis that perturbations in DA neurotransmission may underlie many of the symptoms 
of schizophrenia (Tzschentke, 2001). However, in addition to symptoms of psychosis, 
schizophrenics experience a range of cognitive deficits, including working memory and 
sustained attention (Riehemann, Volz, Stutzer, Smesny, Gaser, & Sauer, 2001). These deficits 
are generally not remedied by DA receptor antagonists (Radek, Kohlhaas, Rueter, & Mohler, 
2010). Schizophrenics tend to display decreased cerebral blood flow in the PFC, which is 
correlated with reduced DA metabolites in cerebral spinal fluid (Weinberger, Berman, & 
Illowsky, 1988), a brain region critically involved in working memory and attention (Christakou, 
Robbins, & Everitt, 2004; Goldman-Rakic, Muly, & Williams, 2000). This has led to the 
hypothesis that reductions in DA neurotransmission in the PFC may underlie the attentional 
deficits of schizophrenia (Weinberger et al., 2001). 
 To test this hypothesis, the present study explored the effects of disrupting DA 
innervation of rat PFC on a sustained attention task modeled after the Continuous Performance 
Task (CPT) (Rosvold, Mirsky, Sarason, Bransome, & Beck, 1956) that is used to assess 
sustained attention in schizophrenics. Before presenting the thesis research itself, the following 
sections will: 1) outline DA function in the PFC in relation to schizophrenia; 2) describe the 
nature of cognitive impairment in schizophrenia; and 3) describe the task used to study neural 
correlates of sustained attention in rodents. 
Prefrontal Cortex Dopamine and Attention 
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An optimal level of D1 receptor stimulation in healthy individuals is required for normal 
working memory and attention (Goldman-Rakic, Muly, & Williams, 2000). In primates, both 
over- and understimulation of D1 receptors in the PFC hinders performance in a working 
memory task (Cai & Arnsten, 1997). Too little or too much DA activity, therefore, may 
negatively affect working memory and attentional performance. 
Lesions to the mPFC using quinolinic acid result in behavioral deficits in a 5-choice 
serial reaction time task (Chudasama, Passetti, Rhodes, Lopian, Desai, & Robbins, 2003). 
However, multiple types of neurons are destroyed by quinolinic acid lesions. This non-specific 
lesion identifies a role of the mPFC but does not identify the effects of disruption to a particular 
kind of neurotransmission within the mPFC. 
Evidence for DA involvement in attention comes from pharmacological manipulations 
demonstrating behavioral effects following direct mPFC D1 agonism and antagonism. This 
manifested as both improved and hindered attentional performance depending on baseline 
performance (Granon, Passetti, Thomas, Dalley, Everitt, & Robbins, 2000). Therefore, the 
present study aimed to further explore the role of reduced DA on attention in rats using a 
controlled DA manipulation.  
Prefrontal Cortex Dopamine and Schizophrenia 
Schizophrenics have reduced density of fibers immunoreactive for tyrosine hydroxlyase, 
the rate-limiting enzyme involved in DA synthesis, in prefrontal cortical layers 3 and 6, (Akil, 
Pierri, Whitehead, Edgar, Mohila, Sampson, & Lewis, 1999). Also, schizophrenics display 
reduced dendritic spine density in post-mortem analyses of the PFC, which may be related to 
decreases in DA innervation (Glantz & Lewis, 2000). In adult rats, DA depletion (>50%) of the 
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ventral tegmental area (VTA) induced by the catecholamine neurotoxin 6-hydroxydopamine (6-
OHDA) results in decreased spine density of layer 5 pyramidal neurons of the mPFC (Wang & 
Deutch, 2008). This suggests that abnormal DA neurotransmission may influence synaptic 
structure, resulting in fewer synapses and impaired PFC function. 
As noted earlier, schizophrenia may involve excess DA in subcortical structures, yet too 
little DA in cortical regions (Knable & Weinberger, 1997; Guillin et al., 2007). Specifically, the 
model involves hypoactivity of the mesocortical DA system, beginning in the VTA and 
terminating in the PFC, paired with hyperactivity of the mesolimbic pathways, which originate in 
the VTA and terminate in the nucleus accumbens, hippocampus, and amygdala. Mesolimbic DA 
overactivity is believed to contribute to psychotic experiences (Goto & Grace, 2007), while 
mesocortical hypoactivity may contribute to cognitive deficit, including sustained attention 
(Meisenzahl et al., 2007).  
Attentional Deficit in Schizophrenia 
The CPT is used to study attentional deficits in schizophrenic patients (Rund, 1998). The 
CPT involves rapidly presenting visual stimuli to subjects in a non-predictable arrangement of 
continuously changing patterns, typically letters or numbers (Riccio, Reynolds, Lowe, & Moore, 
2002). The classic paradigm involves designating the letter “X” as the target, presented within a 
series of letters flashed for 1-2 seconds (Rosvold et al., 1956). When the target is detected, 
subjects respond by pressing a lever. Increasing the complexity of the target adds an additional 
level of difficulty (e.g., requiring that the letter “A” be paired with “X”; Riccio et al.). The 
unpredictability of the stimulus presentation requires subjects to remain vigilant to changing task 
requirements (Hazlett, Dawson, Schell, & Neuchterlein, 2001). 
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Shortening the stimulus duration, adjusting the frequency of target presentation, and 
manipulating perceptual aspects of the target (such as blurring or partially occluding) are 
additional methods of increasing attentional challenge on the CPT (Riccio et al., 2002). 
Cognitive deficits in schizophrenics become more apparent on tasks requiring elevated levels of 
attention (Jazbec, Pantelis, Robbins, Weickert, Weinberger, & Goldberg, 2007), and 
schizophrenics typically require a longer duration of stimulus presentation to perform at control 
levels (Cattapan-Ludewig, Hilti, Ludewig, Vollenweider, & Feldon, 2005). Similar deficits are 
seen in patients with frontal lobe damage, suggesting that poor performance on the CPT is 
related to abnormal PFC function (Riccio et al.).  
The 5-Choice Serial Reaction Time Task  
The 5-choice serial reaction time task (5-CSRTT) is a rodent version of the CPT used to 
assess attention in schizophrenic subjects (Robbins, 2002; see Figure 1). The task assesses an 
animal’s ability to remain vigilant to an array of visual stimuli over a 30-minute test session 
(Carli, Robbins, Evenden, & Everitt, 1983). In this task, rats maintain visual attention to an array 
of five apertures located on one wall of a test chamber. One of these five apertures is lit on a 
pseudorandom schedule for a short period of time; rats learn to poke their nose into the lighted 
aperture to receive a food pellet from a dispenser on the opposite wall of the test chamber. This 
task becomes especially challenging when the length of time that the aperture is lit is reduced. 
By placing additional cognitive demands (e.g., shortening the stimulus duration, introducing a 
noise distracter), the 5-CSRTT provides a method for systematically challenging sustained 
attention in animals analogous to the CPT in humans. 
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The 5-CSRTT engages DA pathways terminating in the rat mPFC (Dalley, Cardinal, & 
Robbins, 2004; Muir, Everitt, & Robbins, 1996). Quinolinic acid lesions of the rat mPFC reduce 
overall PFC neurotransmission and impair performance on the 5-CSRTT (Passetti, Levita, & 
Robbins, 2003). Quinolinic acid lesions glutamatergic and GABAergic neurons, but does not 
reduce tyrosine-hydroxylase-labeled axons in lesion sites (Schwarcz, Whetsell, & Mangano, 
1983). The attention deficit caused by quinolinic acid is remedied by administration of a D2 
receptor antagonist (Passetti, Levita, & Robbins, 2003). This suggests that the mPFC lesion 
hinders performance because the DA system is disrupted. However, it is unclear where the DA 
antagonist is acting in the brain to ameliorate deficits.  
Antagonism of D1 receptors in the mPFC improves baseline performance in the 5-
CSRTT in unlesioned rats performing below the group median (Granon et al., 2000). 
Performance-enhancing effects of dopaminergic pharmacological manipulations in the 5-CSRTT 
suggest that this task assesses cognitive abilities that are dependent on the functional capacity of 
the mesocortical pathway. Consequently, the 5-CSRTT will be used in the present study as a 
behavioral paradigm for investigating the effects of neurochemical disruption to the DA system 
on attentional processes in rodents. 
Present Study 
The present study explored the cognitive effects of insult to dopaminergic 
neurotransmission in the PFC in the rat. Specifically, the effects of 6-OHDA administered into 
the mPFC of rats during the early adulthood period (postnatal day 55) on performance in the 5-





 Male Sprague-Dawley rats (N = 12; Harlan Sprague-Dawley, Inc., Indianapolis, IN.) 
were housed in pairs from arrival at postnatal day (PN) 37 until surgery. Rats were randomly 
assigned to either a sham (n = 5) or lesion (n = 7) condition on the day of surgery. One of the rats 
in the lesion condition did not recover from surgery; as a result, the study included n = 6 rats in 
the lesion condition. Until the start of behavioral testing, rats were given free access to tap water 
and standard rodent chow (Mazuri Rodent Chow, Minneapolis, MN) and were maintained on a 
12:12 hour light/dark cycle with lights on at 7:00 AM. During behavioral testing, ad libitum 
access to tap water was continued, but rats were food deprived to 80-85% of free-feeding body 
weight relative to age-matched controls (~310 grams at start of testing). At all times, rats were 
treated according to the NIH Guidelines for the Care and Use of Laboratory Animals and 
Western Washington University’s local animal use committee.  
Surgery 
 At PN 55 (body weight range 210-270 grams), each rat was given a systemic injection of 
equithesin (3.0 ml/kg) 20 minutes prior to placement in the stereotax (David Kopf Instruments, 
Models 900, 970, and 907, Turjunga, CA). Equithesin anesthesia was supplemented as needed 
throughout the course of the surgery. The surgical procedure involved bilateral microinjections 
of the 6-OHDA (MP Biomedicals, lot #5664J; 1.0 µg base/2 µl vehicle, dissolved in ascorbic 
acid; 2 µl/hemisphere at a flow rate of 0.2 µl/min) or vehicle into the mPFC (+3.2 
anteroposterior, ±0.8 mediolateral, and -3.2 dorsoventral from bregma; Paxinos & Watson, 
1986). To reduce 6-OHDA destruction of norepinephrine (NE) terminals in the mPFC, the NE 
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transporter antagonist desipramine hydrochloride (DMI; Sigma D3900-5G; 25 mg base/kg, 
dissolved in saline immediately prior to use) was administered intraperitoneally 1 hour prior to 
the 6-OHDA injections. Control subjects received an injection of saline, also delivered 
intraperitoneally. 
Immediately following surgery, animals were placed on a heating pad and monitored 
until full recovery, and then individually housed for the duration of the study. 
Behavioral Testing 
Apparatus. Operant conditioning chambers (Model MED-NP9L-B1, Med. Associates Inc., St. 
Albans, VT; 12.0" L x 9.5" W x 8.25" H) were used to assess sustained visual attention in the 5-
CSRTT (see Figure 1). Nose poking into one of nine apertures (2.5 cm2) located on one wall of 
the chamber resulted in delivery of a 45 mg food pellet from a dispenser located on the opposite 
wall. A house light located directly above the food receptacle was illuminated when rats 
responded performed premature, incorrect, or omitted responses. A stainless steel grid floor was 
situated above cob bedding, which was replaced prior to the start of each daily session. There 
were two testing chambers; care was taken to ensure that rats were assigned to the same chamber 
each day. The operant chambers were controlled by a Windows-based computer and interface 
(MEDPC-IV; Med Associates Inc., St. Albans, VT) located outside of the testing room.  
Protocol. Training in the 5-CSRTT began 2 weeks post-surgery. Food deprivation began the day 
before the first training session; body weights were assessed prior to each operant session to 
maintain animals at 80-85% of free-feeding weight. Rats reached this body weight after an 




The goal of habituation sessions was to acclimate each rat to the testing chamber and to 
lead them to associate the light in the food receptacle with delivery of food reward. Animals 
spent 2 days habituating to the testing box. Each habituation session lasted for 30 minutes. 
During each habituation session, a light in the food receptacle was turned on for 30 seconds, and 
shut off for the remaining 30 seconds of each 60-second period. If the rat failed to retrieve the 
pellet within the allotted time period, the house light above the food receptacle was illuminated 
for 5 seconds. The period of time during which a rat could obtain the food pellet once the light in 
the receptacle was turned off is referred to as the limited hold period. The limited hold period 
provided an opportunity for a rat to respond correctly even when the light stimulus had been 
turned off.  
Response-Shaping Phase 
A 2-day response-shaping phase immediately followed the habituation phase. These 
sessions were identical to the habituation sessions except that: 1) the shaping sessions lasted for 
30 minutes or the completion of 100 trials; and 2) each rat had to poke its nose into the food 
receptacle to trigger the delivery of a food pellet. During the response-shaping sessions, rats were 
conditioned to perform a specific nose poke response to the light presented in the food 
receptacle.  
Aperture-Response Phase 
Immediately after the response-shaping phase, the aperture-response phase was initiated. 
During this phase, rats learned to nose poke into one of five apertures located on the wall 
opposite the food receptacle, rather than into the food magazine. Each session during this phase 
 10 
lasted for 30 minutes or 100 complete trials. For each trial, a light was illuminated 
pseudorandomly in one of the five apertures; each rat had to learn to nose poke into the lit 
aperture. Rats learned to pay attention to the wall of apertures in order to correctly detect the 
location of the lit aperture, and then to subsequently collect their food reward from the 
receptacle. Once the food pellet was retrieved, a 5 second inter-trial interval commenced, 
followed by initiation of the next trial. 
When a rat had learned to respond correctly for at least 50 of 100 possible trials over a 
30-minute session, the task difficulty was gradually increased by reducing the amount of time 
that the stimulus aperture was lit on the next testing session. At the beginning of the aperture-
response phase, rats had 30 seconds to locate the illuminated aperture. As the rats acquired the 
task during the aperture-response phase, the length of time that the aperture was illuminated was 
reduced to a 2.5 second duration.  
Probe Trial Phase 
 After a stable performance was achieved (less than 20% omissions; more than 80% 
correct responses) at a 2.5 second stimulus duration over 2 consecutive testing sessions, rats 
began the probe trial phase. During the probe trial phase, the length of stimulus presentation 
during a given session was decreased from 2.5 seconds to one of four different durations (1.5, 
1.0, 0.5, and 0.25 seconds), presented over the course of the next testing session on a 
pseudorandom schedule. The 5-second limited hold period became especially important during 
the probe trial phase, as the light in an aperture was only visible for a short amount of time. This 
made the completion of a nose poke in an aperture while the stimulus was presented difficult, if 
not impossible. Probe trials were not administered on consecutive testing days, meaning that 
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each probe trial was separated by at least one day of testing at baseline parameters (2.5-second 
stimulus duration).  
Each rat was presented with each of the four different stimulus durations on three 
different testing sessions, and each probe trial session continued for 30 minutes or the 
completion of 100 trials. 
Analysis. A correct response was defined as a nose poke into an illuminated aperture or during 
the limited hold period that followed.  
 Additionally, several different types of error are assessed in the 5-CSRTT (see Figure 1; 
Dalley, Cardinal, & Robbins, 2004). An incorrect response is a nose poke response into any of 
the four apertures where the stimulus was not presented. A premature response is a nose poke 
made during the inter-trial period (5 seconds) prior to the stimulus presentation. Lastly, an 
omission occurs when no response is made during the period where the aperture is lit or the 5-
second limited hold period that immediately followed. 
 The frequency of correct responses, omitted responses, number incorrect, and number of 
premature responses made was used to assess performance in lesioned and control rats.  
Neurochemical Analyses 
 Animals were decapitated, their brains removed, and the mPFC rapidly dissected out. The 
tissue was immediately flash-frozen on dry ice and stored at -80ºC. High pressure liquid 
chromatography (HPLC) was used to assess the concentrations of dopamine (DA) and 
norepinephrine (NE) in samples taken from the mPFC of each hemisphere. 
High Pressure Liquid Chromatography. Tissue from a single hemisphere was placed in 
microcentrifuge tubes containing 250 µl of 0.2 M hydrochloric acid, sonicated until 
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homogenous, and then spun at 14,000 rpm for 25 minutes. The liquid portion of the sample was 
removed, placed in new microcentrifuge spin-X tubes, and spun at 10,000 rpm for an additional 
10 minutes. Tissue samples were then frozen at -80ºC until processed using HPLC. 
 The mobile phase circulated through the HPLC system at a flow rate of 0.4 mL/minute, 
and consisted of 75 mM sodium dihydrogen phosphate, 0.025 mM ETDA, 10% acetonitrile, 100 
µl /L triethylamine, and 1.7 mM 1-octanesulfonic acid (sodium salt). The mobile phase was 
vacuum filtered, and adjusted to a pH of 3.0 using 12 N phosphoric acid. A standard solution and 
tissue samples was injected into an HPLC instrument using an autosampler (ESA Model 540, 
Chelmsford, MA) and delivery system (ESA Model 580, Chelmsford, MA). In some cases, the 
tissue samples were manually injected into the HPLC. The standard solution was composed of 
10 µl each of aqueous DA, NE, DOPAC, HVA, and 5-HIAA in 10 mL 0.2 M HCl. Tissue 
samples (20 µl) were injected following analysis of the standard solution. The analytical column 
(15 cm x 3 mm x 3 µm; Supelco, Model Supelcosil™, Bellefonte, PA) was connected to a 
coulometric detection system (ESA Coulochem II, Chelmsford, MA). Chromatograms were 
analyzed on a PC using VARIAN Star Chromatography Workstation (Version 5).  
Data Analysis  
 Each dependent measure (correct responses; omissions; incorrect responses; premature 
responses) was assessed with repeated-measures ANOVAs across five stimulus durations (2.5, 
1.5, 1.0, 0.5, and 0.25 seconds). Furthermore, a Pearson correlational coefficient was calculated 
to determine if correct or omitted responses were related to degree of catecholamine depletion in 
the mPFC. 
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An independent-samples t-test was conducted in order to determine the extent of DA 
depletion in the mPFC of 6-OHDA treated rats and sham controls. HPLC chromatographs were 
quantified by establishing the peak height and base distance of retention time spikes for DA and 
NE. The relative concentrations of neurotransmitters were calculated based on retention time 
chromatographs calibrated from the standard solution.  
Results 
There were significant reductions in both DA and NE tissue content in 6-OHDA treated 
animals relative to controls (for DA, (t(9) = -7.61, p < .001; for NE t(9) = 5.83, p < .001; see 
Table 1). Administration of 6-OHDA in the mPFC reduced DA in the lesioned rats ranging from 
between 16% and 62% of controls (average DA depletion to 33% of controls, S.E.M. = 7.77). NE 
depletion was slightly less robust, ranging from 26% to 65% of controls (average NE depletion 
to 50% of controls, S.E.M. = 6.29). A two-tailed Pearson correlational coefficient did not reveal a 
significant association between NE and DA depletion in lesioned rats (r = .48, p = .34). 
Manipulating task difficulty in the 5-CSRTT by shortening the length of stimulus 
presentation resulted in similar behavioral changes in both lesioned and control animals. As the 
stimulus duration was decreased, both groups of rats were less able to respond correctly and 
there was a corresponding increase in the frequency of omitted, incorrect and premature 
responses (see Tables 2-5).  
Repeated-measures ANOVAs revealed significant overall effects of shortening the 
stimulus duration in both 6-OHDA treated and control rats. As the stimulus duration decreased, 
percent correct responses decreased in both groups [F (4, 36) = 64.30, p < .001; see Figure 2; for 
raw data, see Table 1], and percent omissions increased [F (4, 36) = 60.11, p < .001; see Figure 
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3; for raw data, see Table 2]. Furthermore, shortened stimulus durations resulted in a significant 
increase in the number of incorrect responses [F (4, 36) = 61.37, p < .001; see Figure 4], and the 
number of premature responses [F (4, 36) = 31.86, p < .001; see Figure 5] in both groups.  
The 6-OHDA treated rats tended toward increased omissions at four out of five stimulus 
durations, and tended toward less correct at three out of five stimulus durations. However, 
repeated-measures ANOVAs did not reveal a significant interaction of lesion x stimulus duration 
on percent correct responses [F (4, 36) = 0.40, p = 0.81], or percent omitted responses [F (4, 36) 
= 1.13, p = 0.36]. The number of incorrect responses did not differ significantly between groups 
[F (4, 36) = 1.30, p = 0.29], nor did premature responses [F (4, 36) = 0.17, p = 0.95]. 
Furthermore, correlations between the degree of DA and NE depletion and number correct and 
omitted were not significant at stimulus durations of 0.25, 0.5, 1.0, or 1.5 seconds (data not 
shown). 
 Discussion 
The catecholamine neurotoxin 6-OHDA administered into the mPFC of rats significantly 
depleted DA, and to a lesser extent NE. Dopamine lesions to the mPFC resulted in a trend 
toward increased omissions and reduced correct responses, particularly at more challenging 
stimulus durations. However, these depletions did not significantly impair rats’ performance in 
the 5-CSRTT.  
The lack of effect of 6-OHDA in the present study is surprising given the role of DA and 
cognition in the PFC (Goldman-Rakic, Muly, & Williams, 2000). A trend toward poorer 
performance in 6-OHDA treated animals suggests that the nonsignificant results are attributable 
to small group sizes or lack of sensitivity in the 5-CSRTT to detect attentional dysfunction in 
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lesioned rats. Alternately, when rats sustain combined NE and DA loss in the mPFC, 
extracellular DA concentrations in the mPFC were not different from controls (Venator, Lewis, 
& Finlay, 1999). It has been suggested that in the absence of NE reuptake proteins to clear 
extracellular DA, concentrations of DA in the synapse are maintained at normal levels.  
Quinolinic acid lesions of the mPFC, but not the parietal or cingulate cortex, impair 5-
CSRTT performance, suggesting that sustained attention assessed by this task is dependent on 
the mPFC (Muir, Everitt, & Robbins, 1996). By contrast, in the present study behavioral deficits 
were not observed despite significant catecholamine depletion in the mPFC. The goal of 6-
OHDA induced DA depletion of the mPFC in the present study was to mimic the type of DA 
disruption seen in post-mortem analyses of schizophrenics (Akil et al., 1999). However, it is 
possible that 6-OHDA neurotoxic effects are not enough to functionally impair rats in the 5-
CSRTT compared to those with mPFC quinolinic acid lesions, which affects predominantly 
glutamatergic and GABAergic neurotransmission in lesioned brain regions (Scharcz, Whetsell, 
& Mangano, 1983). 
Inherent variability in rats’ ability in the 5-CSRTT may have diminished the likelihood of 
detecting group differences in the present study, particularly in light of small group sizes. Granon 
et al. (2000) found that administration of the D1 agonist SCH 38393 into the mPFC improved 
accuracy in rats categorized as exhibiting lower baseline accuracy (<75% correct at a stimulus 
duration of 0.5 seconds). Alternately, antagonism of D1 receptors using SCH 23390 impaired 
accuracy in rats exhibiting higher baseline accuracy (>75% correct at stimulus durations between 
0.5 and 0.25 seconds). The different responses to dopaminergic pharmacological manipulation 
between high and low performing rats suggests that DA activity in the mPFC may be vary due to 
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differences in endogenous DA neurotransmission in low- and high-performing rats. Likewise, 
behavioral deficits in the 5-CSRTT due to DA depletions may not be detected when rats innately 
performing at different levels are treated equally. Future studies might train rats in the 5-CSRTT 
prior to surgical manipulation in order to separate low- and high-performing rats before assessing 
the behavioral effects of 6-OHDA lesions. This would require larger sample sizes than those 
used in the present study.  
The trend toward increased omissions in the lesioned group emerged in four out of five 
testing sessions, and was observed in trials with the shortest stimulus durations (0.5 and 0.25 
seconds). Taking this into account, the trend toward performance deficit under challenging task 
circumstances should be explored in future studies utilizing 6-OHDA lesions at even shorter 
durations (ie., 0.10 and 0.05 seconds). It is possible that the baseline and limited stimulus 
durations used in the present study (2.5, 1.5, 1.0, 0.5, and 0.25 seconds) did not provide the 
challenge necessary to detect attentional dysfunction in DA depleted rats.  
Another methodological consideration is that the 5-CSRTT testing session lasts for 100 
trials or 30 minutes, whichever is longer. As the rats learn to perform at a criterion of >80% 
correct and <20% omitted responses at a 2.5 second stimulus duration, in nearly all animals the 
length of the testing session was “timed out,” meaning that the animals reached 100 trials before 
30 minutes. In many cases, the length was cut almost in half. Future studies could test 
performance in the 5-CSRTT if rats were required to maintain vigilant for the full 30 minutes 
under challenging testing conditions with shortened stimulus durations.  
In the current study, the NE transporter antagonist DMI was administered to prevent 6-
OHDA from damaging NE-containing neurons. Unexpectedly, 6-OHDA-treated animals 
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sustained ~50% NE depletion in addition to ~67% DA depletion in the mPFC. In previous work, 
administration of 6-OHDA using a similar protocol decreased NE tissue concentrations by 15-
35% (e.g., Venator, Lewis, & Finlay, 1999). Given the larger NE depleting in the present study, 
it is possible that less NE in the mPFC resulted in masking the DA depletion resulting from 6-
OHDA. The reasons for greater NE loss in the present study are unclear, but one possibility is 
that the batch of DMI used was ineffective for unknown reasons. Despite this unresolved issue, 
catecholamine depletion did not produce deficits on 5-CSRTT performance.  
The aim of this thesis was to study the effects of DA depletions in the mPFC of rats on 
sustained attention performance. Trends toward poorer performance in lesioned animals should 
be explored in future studies with larger sample sizes. These trends support a possible role of DA 
and NE in the mPFC in modulating sustained attention while having no effect on impulsivity, 
consistent with other reports of DA agonists affecting response selection and not premature 
responding (Passetti, Dalley, & Robbins, 2003). 
The trend in results suggests that DA in the PFC may play a role in attentional 
dysfunction in schizophrenia. Schizophrenia may involve imbalance of DA neurotransmission of 
cortical and subcortical sites, posing a challenge in developing pharmaceutical treatments. This 
challenge is further compounded by the heterogeneity of symptoms in schizophrenia, as both 
psychotic symptoms and cognitive deficits have considerable detriments in occupational and 
social settings. Unfortunately, current pharmacological therapy is primarily used to treat 
psychotic symptoms, and does not directly address the cognitive deficits (Wassef, Dott, Harris, 
Brown, O’Boyle, Meyer, et al., 1999). Complex interactions both within DA systems and 
between DA and other neurotransmitter systems in the PFC remain to be elucidated. Further 
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research is needed in order to elucidate the possible role of DA in cognitive deficits, and to 




Table 1. Means and standard deviations of mPFC tissue dopamine (DA), norepinephrine (NE), 
assayed by high-pressure liquid chromatography. 
 
Relative Concentrations (expressed as ng/mg tissue wet weight) 
      DA         NE     
______________________________________________________________________________ 
6-OHDA (n=6)  0.04 (0.02)**   0.25 (0.08)**    
Control (n=5)   0.13 (0.01)   0.48 (0.05)   
    
** p < .001 
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Table 2. Means and standard deviations of correct responses of 6-OHDA treated and sham 
control rats. 
 
Stimulus Duration (seconds) 
2.5  1.5  1.0  0.5  0.25 
______________________________________________________________________________ 
6-OHDA (n=6) 83.3 ± 5.5     69.2 ± 7.4        64.3 ± 6.7       36.9 ± 10.9        18.1 ± 5.1 
Control (n=5)  83.8 ± 3.9     75.6 ± 8.5        64.7 ± 8.2       41.7 ± 5.5          23.9 ± 6.6 
Total   83.6 ± 4.6     72.1 ± 8.2        64.5 ± 12.9     39.1 ± 8.8          20.7 ± 6.3 
______________________________________________________________________________
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Table 3. Means and standard deviations of omitted responses of 6-OHDA treated and sham 
control rats. 
 
     Stimulus Duration (seconds) 
2.5  1.5  1.0  0.5  0.25 
______________________________________________________________________________ 
6-OHDA           9.6 ± 4.4        18.7 ± 8.3        23.0 ± 15.7      37.8 ± 15.5       50.3 ± 13.7 
Control         10.0 ± 4.1        12.1 ± 7.7        20.3 ± 11.2      29.0 ± 7.3         40.0 ± 12.5 






 Table 4. Means and standard deviations of incorrect responses of 6-OHDA treated and control 
rats. 
______________________________________________________________________________ 
Stimulus Duration (seconds) 
2.5  1.5  1.0  0.5  0.25 
______________________________________________________________________________ 
6-OHDA (n=6) 4.0 ± 3.2        7.3 ± 4.2          8.2 ± 6.1         16.4 ± 7.8         20.1 ± 8.2 
Control (n=5)  3.5 ± 2.3        7.7 ± 5.0        10.4 ± 5.8         19.8 ± 6.4         25.3 ± 8.3 






Table 5. Means and standard deviations of premature responses of 6-OHDA treated and control 
rats. 
 
Stimulus Duration (seconds) 
2.5  1.5  1.0  0.5  0.25 
______________________________________________________________________________ 
6-OHDA (n=6) 3.1 ± 2.4        4.7 ± 1.0          4.4 ± 2.2         8.9 ± 2.7         11.6 ± 3.8 
Control (n=5)  2.7 ± 2.6        4.3 ± 4.2          4.6 ± 4.1         9.5 ± 4.0         10.9 ± 5.8 




Figure 1. Possible responses in the 5-choice serial reaction time task over the 30-minute testing 
session. (Dalley, Cardinal, & Robbins, 2004). 
Figure 2. Percent correct* responses in control and 6-OHDA treated animals (error bars = 
S.E.M.). *% Correct = # Correct / Correct + Incorrect 
Figure 3. Percent omissions* in control and 6-OHDA treated animals (error bars = S.E.M.).  
*% Omitted = # Omissions / Omissions + Correct + Incorrect 
Figure 4. Number of premature responses in control and 6-OHDA treated animals (error bars = 
S.E.M.). 






















Abi-Dargham, A., & Moore, H. (2003). Prefrontal DA transmission at D1 receptors and the 
pathology of schizophrenia. Progress in Clinical Neuroscience, 9(5), 404-416. 
Akil, M., Pierri, J. N., Whitehead, R. E., Edgar, C. L., Mohila, C., Sampson, A. R., & Lewis, D. 
A. (1999). Lamina-specific alterations in the dopamine innervation of the prefrontal 
cortex in schizophrenic subjects. American Journal of Psychiatry, 156(10), 1580-1589. 
Cai, J. X., & Arnsten, A. F. (1997). Dose-dependent effects of the dopamine D1 receptor 
agonists A77636 or SKF81297 on spatial working memory in aged monkeys. Journal of 
Pharmacological Experimental Therapy, 283(1), 183-189. 
Carli, M., Robbins, T. W., Evenden, J. L., & Everitt, B. J. (1983). Effects of lesions to ascending 
noradrenergic neurons on performance of a 5-choice serial reaction task in rats: 
Implications for theories of dorsal noradrenergic bundle function based on selective 
attention and arousal. Behavioural Brain Research, 9, 361-380. 
Cattapan-Ludewig, K., Hilti, C. C., Ludewig, S., Vollenweider, F. X., & Feldon, J. (2005). Rapid 
visual information processing in schizophrenic patients: The impact of cognitive load and 
duration of stimulus presentation. Neuropsychobiology, 52, 130-134. 
Christakou, A., Robbins, T. W., & Everitt, B. J. (2004). Prefrontal cortical-ventral striatal 
interactions involved in affective modulation of attentional performance: Implications for 
corticostriatal circuit function. The Journal of Neuroscience, 24(4), 773-780. 
Chudasama, Y., Passetti, F., Rhodes, S. E., Lopian, D., Desai, A., & Robbins, T. W. (2003). 
Dissociable aspects of performance on the 5-choice serial reaction time task following 
lesions of the dorsal anterior cingulated, infralimbic, and orbitofrontal cortex in the rat: 
 31 
Differential effects on selectivity, impulsivity, and compulsivity. Behavioral Brain 
Research, 146(1-2), 105-119. 
Clinton, S. M., Sucharski, I. L., & Finlay, J. M. (2006). Desipramine attenuates working memory 
impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex. 
Psychopharmacology 183(4), 404-412. 
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004). Prefrontal executive and cognitive 
functions in rodents: Neural and neurochemical substrates. Neuroscience and 
Biobehavioral Reviews, 28, 771-784.  
Finlay, J. M. (2001). Mesoprefrontal dopamine neurons and schizophrenia: Role of 
developmental abnormalities. Schizophrenia Bulletin, 27(3), 431-442. 
Glantz, L. A., & Lewis, D. A. (2000). Decreased dendritic spine density on prefrontal cortical 
pyramidal neurons in schizophrenia. Archives of General Psychiatry, 57, 65-73. 
Goldman-Rakic, P. S., Muly, E. C., & Williams, G. V. (2000). D1 receptors in prefrontal cells 
and circuits. Brain Research Reviews, 31, 295-301. 
Goto, Y., & Grace, A. A. (2007). The dopamine system and the pathophysiology of 
schizophrenia: A basic science perspective. International Review of Neurobiology, 78, 
41-68. 
Granon, S., Passetti, F., Thomas, K. L., Dalley, J. W., Everitt, B. J., & Robbins, T. W. (2000). 
Enhanced and impaired attentional performance after infusion of D1 dopaminergic 
receptor agents into rat prefrontal cortex. The Journal of Neuroscience, 20, 1208-1215. 
Gu, Q. (2002). Neuromodulatory transmitter systems in the cortex and their role in cortical 
plasticity. Neuroscience, 111(4), 815-835. 
 32 
Guillin, O., Abi-Dargham, A., & Laruelle, M. (2007). Neurobiology of dopamine in 
schizophrenia. International Review of Neurobiology, 78, 1-39. 
Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., 
Lewis, D. A. (2003). Gene expression deficits in a subclass of GABA neurons in the 
prefrontal cortex of subjects with schizophrenia. The Journal of Neuroscience, 23(15), 
6315-6326. 
Hazlett, E. A., Dawson, M. E., Schell, A. M., & Neuchterlein, K. H. (2001). Attentional stages of 
information processing during a continuous performance test: A startle modification 
analysis. Psychophysiology, 38, 669-677. 
Jazbec, S., Pantelis, C., Robbins, T. W., Weickert, T., Weinberger, D. R., & Goldberg, T. E. 
(2007). Intra-dimensional/extra-dimensional set-shifting performance in schizophrenia: 
Impact of distractors. Schizophrenia Research, 89, 339-349. 
Knable, M. B., & Weinberger, D. R. (1997). Dopamine, the prefrontal cortex, and schizophrenia. 
Journal of Psychopharmacology, 11(2), 123-131. 
Krasnova, I. N., Betts, E. S., Dada, A., Jefferson, A., Ladenheim, B., Becker, K. G., et al. (2007). 
Neonatal dopamine depletion induces changes in morphogenesis and gene expression in 
the developing cortex. Neurotoxicity Research, 11(2), 107-130. 
Lewis, D. A., Cruz, D., Eggan, S., & Erickson, S. (2004). Postnatal development of prefrontal 
inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia. 
Annals New York Academy of Sciences, 1021, 64-76. 
Lewis, D. A., Hashimoto, T., Volk, D. W. (2005). Cortical inhibitory neurons and schizophrenia. 
Nature Reviews Neuroscience, 6, 312-324.  
 33 
Meisenzahl, E. M., Scheuerecker, J., Schmitt, G. J. S., & Möller, H. J. (2007). Dopamine, 
prefrontal cortex and working memory functioning in schizophrenia. 
Pharmacopsychiatry, 40(Suppl. 1), S62-S72. 
Muir, J. L., Everitt, B. J., & Robbins, T. W. (1996). The cerebral cortex of the rat and visual 
attentional function: Dissociable effects of mediofrontal, cingulated, anterior dorsolateral, 
and parietal cortex lesions on a five-choice serial reaction time task. Cerebral Cortex, 
6(3), 470-481. 
Passetti, F., Levita, L., & Robbins, T. W. (2003). Sulpiride alleviates the attentional impairments 
of rats with medial prefrontal cortex lesions. Behavioural Brain Research, 138, 59-69. 
Paxinos, G., & Watson, C. (1986). The Rat Brain in Stereotaxic Coordinates. Mamckville, 
Australia: Academic Press. 
Radek, R. J., Kohlhaas, K. L., Rueter, L. E., & Mohler, E. G. (2010). Treating the cognitive 
deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists. Current 
Pharmaceutical Design, 16(3), 309-322. 
Raedler, T. J., Knable, M. B., & Weinberger, D. R. (1998). Schizophrenia as a developmental 
disorder of the cerebral cortex. Current Opinion in Neurobiology, 8, 157-161. 
Rapaport, J. L., Addington, A. M., Frangou, S. & Psych, M. R. C. (2005). The 
neurodevelopmental model of schizophrenia: Update 2005. Molecular Psychiatry, 10, 
434-449.  
Riccio, C. A., Reynolds, C. R., Lowe, P., & Moore, J. J. (2002). The continuous performance 
test: A window on the neural substrates for attention? Archives of Clinical 
Neuropsychology, 17, 235-272. 
 34 
Riehemann, S., Volz, H. P., Stuzter, P., Smesny, S., Gaser, C., & Sauer, H. (2001). 
Hypofrontality in neuroleptic-naïve schizophrenic patients during the Wisconsin Card 
Sorting Test: A fMRI study. Archives of Clinical Neuroscience, 251(2), 66-71. 
Robbins, T. W. (2002). The 5-choice serial reaction time task: Behavioural pharmacology and 
functional neurochemistry. Psychopharmacology, 163, 362-380. 
Rosvold, H. E., Mirsky, A. F., Sarason, I., Bransome, E. D., & Beck, L. H. (1956). A continuous 
performance test of brain damage. Journal of Consulting Psychology, 20(5), 343-350. 
Rund, B. R. (1998). A review of longitudinal studies of cognitive functions in schizophrenic 
patients. Schizophrenia Bulletin, 24(3), 425-435.  
Scharwcz, R., Whetsell, W. O. Jr., & Mangano, R. M. (1983). Quinolinic acid: An endogenous 
metabolite that produces axon-sparing lesions in rat brain. Science, 219, 316-318. 
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001). A review of MRI 
findings in schizophrenia. Schizophrenia Research, 49, 1-52. 
Tzschentke, T. M. (2001). Pharmacology and behavioral pharmacology of the mesocortical 
dopamine system. Progress in Neurobiology, 63, 241-320. 
Venator, D. K., Lewis, D. A., & Finlay, J. M. (1999). Effects of partial dopamine loss in the 
medial prefrontal cortex on local baseline and stress-evoked extracellular dopamine 
concentrations. Neuroscience, 93(2), 497-505. 
Wang, H., & Deutch, A. Y. (2008). Dopamine depletion of the prefrontal cortex induces 
dendritic spine loss: Reversal by atypical antipsychotic drug treatment. 
Neuropsychopharmacology, 33, 1276-1286. 
 35 
Wassef, A. A., Dott, S. G., Harris, A., Brown, A., O’Boyle, M., Meyer, W. J., & Rose, R. M. 
(1999). Critical review of GABA-ergic drugs in the treatment of schizophrenia. Journal 
of Clinical Psychopharmacology, 19, 222-232.  
Weinberger, D. R., Berman, K. F., & Illowsky, B. P. (1988). Physiological dysfunction of 
dorsolateral prefrontal cortex in schizophrenia: A new cohort and evidence for a 
monoaminergic mechanism. Archives of General Psychiatry, 45, 609-615. 
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., et al. 
(2001). Neurobiology of schizophrenia and the role of atypical antipsychotics: Prefrontal 
neurons and the genetics of schizophrenia. Biological Psychiatry, 50, 825-844. 
 
 
